Ken Griffin’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,387
Closed -$42.9K 14329
2025
Q4
$42.9K Sell
8,387
-8,089
-49% -$61.4K ﹤0.01% 12106
2025
Q3
$224K Buy
16,476
+6,789
+70% +$90.4K ﹤0.01% 11027
2025
Q2
$147K Buy
+9,687
New +$107K ﹤0.01% 10974
2025
Q1
Sell
-3,410
Closed -$40.9K 15646
2024
Q4
$40.9K Buy
+3,410
New +$45.8K ﹤0.01% 12602
2024
Q3
Sell
-1
Closed -$13 15339
2024
Q2
$18 Buy
+1
New +$15 ﹤0.01% 14122
2023
Q3
Sell
-316
Closed -$8.78K 15199
2023
Q2
$8.78K Sell
316
-700
-69% -$23K ﹤0.01% 13296
2023
Q1
$38.8K Sell
1,016
-3,082
-75% -$129K ﹤0.01% 12463
2022
Q4
$199K Sell
4,098
-1,096
-21% -$42.6K ﹤0.01% 10149
2022
Q3
$141K Buy
5,194
+3,910
+305% +$148K ﹤0.01% 10778
2022
Q2
$53K Sell
1,284
-23
-2% -$1.16K ﹤0.01% 11900
2022
Q1
$79K Buy
1,307
+760
+139% +$43.1K ﹤0.01% 12485
2021
Q4
$34K Sell
547
-407
-43% -$27.8K ﹤0.01% 13426
2021
Q3
$59K Buy
+954
New +$60.4K ﹤0.01% 13276
2020
Q3
Sell
-644
Closed -$50K 10794
2020
Q2
$50K Buy
+644
New +$46.5K ﹤0.01% 9307

Other funds holding VNRX

Ken Griffin's VNRX Position: Q1 2026 in Review

Ken Griffin sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 8,387 shares — an estimated $42.9K sold.

Ken Griffin first reported a position in VNRX in Q2 2020 and held it in 14 quarters. The position peaked at $224K in Q3 2025. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Ken Griffin reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 8,387 VolitionRx Ltd shares in Q1 2026, an estimated $42.9K.
  • Ken Griffin first reported a position in VolitionRx Ltd in Q2 2020 and held it in 14 quarters.
  • Ken Griffin's VolitionRx Ltd position peaked at $224K in Q3 2025.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.